rs148176750
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_004612.4(TGFBR1):c.415A>G(p.Ile139Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,614,184 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004612.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TGFBR1 | NM_004612.4 | c.415A>G | p.Ile139Val | missense_variant | 3/9 | ENST00000374994.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TGFBR1 | ENST00000374994.9 | c.415A>G | p.Ile139Val | missense_variant | 3/9 | 1 | NM_004612.4 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.000204 AC: 31AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000259 AC: 65AN: 251066Hom.: 1 AF XY: 0.000310 AC XY: 42AN XY: 135678
GnomAD4 exome AF: 0.000136 AC: 199AN: 1461870Hom.: 1 Cov.: 32 AF XY: 0.000139 AC XY: 101AN XY: 727236
GnomAD4 genome ? AF: 0.000204 AC: 31AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74480
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Benign:5
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Nov 08, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Dec 23, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Human Genetics, Inc, Center for Human Genetics, Inc | Nov 01, 2016 | - - |
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 13, 2017 | Variant summary: The c.415A>G (p.Ile139Val) in TGFBR1 gene is a missense change that involves the alteration of a non- conserved nucleotide and 5/4 in silico tools predict benign outcome. The variant was observed in the control datasets of the ExAC and gnomAD at a frequency of 0.00025 (24/121346 and 62/245812 chrs tested, including 1 homozygote). The observed frequency exceeds the maximal expected allele frequency for a pathogenic variant in this gene (0.000002). The variant has been identified in 1 individual with suspected MSF/LDS or TAAD, without strong evidence for causality (Lerner-Ellis_2014). In addition, one clinical laboratory reports co-occurrence of this variant with unspecified pathogenic cardiogenetic variant with disclosure that segregation analysis was not performed. Although several reputable databases/diagnostic centers classified the variant of interest as VUS/Likely Benign, by applying ACMG rules the variant was classified as Likely Benign. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 11, 2016 | proposed classification - variant undergoing re-assessment, contact laboratory - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | TGFBR1: BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 24, 2020 | This variant is associated with the following publications: (PMID: 24793577) - |
Loeys-Dietz syndrome 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Loeys-Dietz syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at